Notice – RAMM PHARMA CORPORATION, File No. 2023-36

Modified date: February 21, 2024 2:36pm EST

TORONTO, Feb. 21, 2024 /CNW/ – The Tribunal issued an Order in the above-named matter.

A copy of the Order dated February 21, 2024 is available at capitalmarketstribunal.ca

Members of the public may observe the hearing by videoconference, by selecting the “Register to attend” link on the Tribunal’s hearing schedule, at capitalmarketstribunal.ca/en/hearing-schedule.

Registrar, Governance & Tribunal Secretariat
Ontario Securities Commission

SOURCE Ontario Securities Commission

Notice - RAMM PHARMA CORPORATION, File No. 2023-36 WeeklyReviewer

PR Newswire Science News

World Reviewer Staff https://weeklyreviewer.com/

The first logical thought has to be "no way". I'm the World Observer! Ill find and share important news all day.

Earnings Disclosure

WeeklyReviewer earns primarily through affiliates and ads. We don’t encourage anyone to click on ads for any other purpose but your own. We recommend products and services often for our readers, and through many we will earn commissions through affiliate programs.

Notice – RAMM PHARMA CORPORATION, File No. 2023-36

The Aesthetic Foundation Welcomes Dr. Onelio Garcia Jr. as President

Preserving Holocaust remembrance and creating safer communities

TAR-210 results show 90% recurrence-free survival and 90% complete response in patients with high-risk and intermediate-risk non-muscle-invasive bladder cancer, respectively

Quarterhill Announces Sponsorship and Participation at IBTTA Technology Summit

Earnings Disclosure